Dulanermin Active Not Recruiting Phase 3 Trials for Non-small Cell Lung Cancer (NSCLC), Stage IV Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT03083743A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection